The profit-driven veterinarian that is the CEO of Pfizer needs to cool his jets!
Dr. Boege is not only brilliant but, also dedicated to understanding the IMMUNE SYSTEM IN REGARD TO INTERACTIONS OF THE HUMAN HEART.
Dr. Boege found out that the bioreceptors in the heart will accept and react to many compounds, including the body's own immune system causing irreparable damage.
The article below is about a compound and was published in 2010. What Dr. Boege and his colleagues were finding out is that anything that enters the body for any reason can result in heart damage. This article was particularly interesting because they even address the issue of the REPAIR of damaged DNA.
Mycotoxin Res., 2010 Nov;26(4):247-5doi: 10.1007/s12550-010-0063-6. Epub 2010 Jul 27.
Alternariol (AOH) (click here) was reported recently to act as a topoisomerase poison. To underline the relevance of topoisomerase targeting for the genotoxic properties of AOH, we addressed the question whether human tyrosyl-DNA phosphodiesterase 1 (TDP1), an enzyme vital to the repair of covalent DNA-topoisomerase adducts, affects AOH-mediated genotoxicity. The relevance of TDP1 activity on AOH-induced genotoxicity was investigated by the comet assay in human cells overexpressing GFP chimera of TDP1 or the inactive mutant TDP1(H263A) as well as in cells subjected to siRNA-mediated knock-down of endogenous TDP1. Cells overexpressing TDP1 exhibited significantly less DNA damage after treatment with AOH in comparison to cells expressing the inactive mutant TDP1(H263A). In accordance with these results, levels of AOH inducing DNA strand breaks were increased in TDP1-suppressed cells in comparison to cells transfected with control siRNA. The specific topoisomerase poisons camptothecin and etoposide caused comparable effects, underlining that TDP1 plays an important role in the repair of topoisomerase-mediated DNA damage. In summary, the repair enzyme TDP1 was identified as a factor for the modulation of AOH-mediated DNA damage in human cells.
Dr. Boege has done extensive research and even examines the specific receptors of the heart and their potential for accepting compounds that cause such damage.
Angela Wölfel, Mathias Sättele, Christina Zechmeister, Viacheslav O. Nikolaev, Martin J. Lohse, Fritz Boege, Roland Jahns, and Valérie Boivin‐Jahns
The conformational auto‐epitope targeted by cardio‐pathogenic β1‐receptor autoantibodies is faithfully conserved in cyclopeptide homologues of the β1ECII loop bearing the NDPK211–214 motif and the C209↔C215 bridge while lacking cysteine C216. Such molecules provide promising tools for novel diagnostic and therapeutic approaches in β1‐autoantibody‐positive CHF.
Keywords: Antibody/autoantibody, β1‐adrenoceptor/β1‐adrenergic receptor, Chronic heart failure, Conformational auto‐epitope, Cyclic peptides/cyclopeptides, Cyclopeptide therapy
Dr. Boege and his colleagues in their decades of research have unearthed the very reason it is far better to examine the exact properties of the vaccines turning loose the immune system to wreak havoc on the heart muscle.
I have a real problem with CEOs that release discoveries on a QUARTERLY basis rather than when it is prudent to do so as all parameters of research show a benign, but, beneficial effect on the body. That is exactly what the Pfizer CEO is doing. He has planned his release of discoveries of the vaccine based on profit margins and a steadfast return on investment quarterly by stockholders of Pfizer to insure his CEO bonuses and expectations by stockholders to his real genius in earning profits for the company based on the vaccination industry.
Unlike cows that are treated in a herd, human beings should be treated expeditiously as BENEVOLENT discoveries are realized in actual reality rather than Wall Street priorities.
The research by Dr. Boege that initially got my attention was this:
February 9, 1999The children and teenagers being vaccinated are being attacked by the immunity developed in the body in reaction to Pfizer's vaccine that was supposed to be developed just for their age group.
I question that.
I think the initial vaccine by Pfizer was simply run through enough experimental trials to find a conclusion that their vaccine is immunity for everyone regardless of age. Pfizer will be releasing their infant vaccine in the upcoming quarter and it needs to be halted to understand FAR BETTER the immune response of young people to mRNA vaccines. Children are still growing and developing their immune systems. I find the idea of such POTENTIAL for a vaccine to do harm in young people and infants especially horrifying. If the FDA and CDC and their advisory panels don't suspend the use of the Pfizer vaccine to infants, then perhaps a conscience at the NIH can find real conclusions to these issues.
Every blade of grass must be turned over and examined in these vaccines for children to INSURE each and every human child will benefit from the vaccine rather than cause irreparable damage to children by the thousands.
Perhaps Wall Street needs to understand that profits ultimately causing damage to the consumer will ultimately fail in providing real profits when sued for the damage these CEO decisions have resulted in.
The USA, nor any other country on Earth, can afford to have any percentage of children afflicted with shorter longevity and/or permanently handicapped and quite possibly incapacitated from their potential to contribute to the country in any measure.
